# Lung Cancer

Episode podcast teratas
Diperbarui:

Ep 128. Perspectives on RET+ Lung Cancer

In this episode, Dr. Paul Wheatley-Price sits down with Patricia and Jim Leong, competitive figure skaters who have represented Canada on the national and international stage, along with Dr. Kirsten Perdrizet, Medical Oncologist at William Osler Health System, for a candid conversation about living…

Morning Prayers (Praise; God our Refuge; Forgiveness; Body of Christ; Pastors / Families; Lung Cancer; Knee & Joint Pain; Human Trafficking; Friends Praying With Me; Straight Paths)

Send us Fan Mail Morning Prayers (Praise; God our Refuge; Forgiveness; Body of Christ; Pastors / Families; Lung Cancer; Knee & Joint Pain; Human Trafficking; Friends Praying With Me; Straight Paths) Thank you for listening, our heart's prayer is for you and I to walk daily with Jesus, our joy and p…

My Dog Tripped Me — Then the CT Scan Said 'Surprise: Lung Cancer'

She tripped over her dog, got a shoulder CT, and oh look — an early-stage lung cancer. So yes, apparently pets now double as medical screening devices. After a minimally invasive VATS procedure removed the tiny tumor, she chose surveillance over chemo, lives near refineries (because why not), and …

🧬 One Mutation, Massive Risk: EGFR T790M and Inherited Lung Cancer

🧬 Rare Variant, Real Risk: EGFR T790M and Lung Cancer Can lung cancer risk be inherited—even in never-smokers? 🫁🚭 In >3.3 million individuals, germline EGFR T790M was rare (~1 in 15,850) but strongly associated with lung cancer (OR 25.18). The association was particularly striking among never-smo…

Dr. Timothy Burns: Precision Lung Cancer Therapy | Ep. 15

In this episode of The Oncology Insights Podcast, I speak with Dr. Timothy Burns, Professor of Medicine at The Ohio State University, about KRAS inhibitors within the evolving spectrum of systemic therapies for Non-Small Cell Lung Cancer (NSCLC). We discuss KRAS mutations, treatment resistance, imm…

How to Actually Manage Cancer Claims In Self-Funded Plans | with Peter Bridges

"Over 90% of the time, there is some change recommended to the care path someone is on. Oftentimes we make two to four separate recommendations." - Peter Bridges, AccessHope Cancer is one of the largest cost drivers in any self-funded plan, and most of the strategies built to manage it focus on pr…

Episode 64: Updates on Lung Cancer from 2026-WCLC

The World Congress on Lung Cancer in Seoul has just concluded, and the insightful Dr. Chul Kim of Georgetown University and Medstar Health joined #HealthcareUnfiltered EXPRESS to share his valuable opinions on practice changing/informing data presented at the meeting.Please share, subscribe, and jo…

Lung Cancer — Proceedings from a Symposium Held in Conjunction with the American Oncology Network

Featuring perspectives from Dr Stephen V Liu and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics: Introduction (0:00) EGFR Mutations (2:23) HER2 Alterations (22:40) Available and Investigational Immunotherapies (32:14) Small Cell Lung Cancer (40:48) CME in…

Lung Cancer — Proceedings from a Symposium Held in Conjunction with the American Oncology Network

Featuring perspectives from Dr Stephen V Liu and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics: Introduction (0:00) EGFR Mutations (2:23) HER2 Alterations (22:40) Available and Investigational Immunotherapies (32:14) Small Cell Lung Cancer (40:48) CME information…

Lung Cancer — Proceedings from a Symposium Held in Conjunction with the American Oncology Network

Featuring perspectives from Dr Stephen V Liu and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics: Introduction (0:00) EGFR Mutations (2:23) HER2 Alterations (22:40) Available and Investigational Immunotherapies (32:14) Small Cell Lung Cancer (40:48) CME information…